Dublin, June 29, 2023 (GLOBE NEWSWIRE) -- The "Viral Vector Manufacturing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Viral Vector Manufacturing estimated at US$661.8 Million in the year 2022, is projected to reach a revised size of US$2.5 Billion by 2030, growing at a CAGR of 18.3% over the analysis period 2022-2030.
Retroviral Vectors, one of the segments analyzed in the report, is projected to record a 18.2% CAGR and reach US$935.6 Million by the end of the analysis period.
Taking into account the ongoing post pandemic recovery, growth in the Adenoviral Vectors segment is readjusted to a revised 18.6% CAGR for the next 8-year period.
The U.S. Market is Estimated at $397 Million, While China is Forecast to Grow at 21.5% CAGR
The Viral Vector Manufacturing market in the U.S. is estimated at US$397 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$107.9 Million by the year 2030 trailing a CAGR of 21.5% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 15.6% and 15.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 14.7% CAGR.
Select Competitors (Total 80 Featured) -
- Batavia Biosciences B.V.
- BioNTech IMFS GmbH
- Cobra Biologics Ltd.
- FinVector Oy
- FUJIFILM Diosynth Biotechnologies
- Genelux Corporation
- Kaneka Eurogentec S.A.
- Lonza Group AG
- MaxCyte, Inc.
- Merck KGaA
- Novasep Inc.
- Oxford BioMedica plc
- Sirion-Biotech GmbH
- Spark Therapeutics, Inc.
- Thermo Fisher Scientific Inc.
- Vector Biolabs
- Vigene Biosciences, Inc.
- Virovek, Inc.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 402 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $661.8 Million |
| Forecasted Market Value (USD) by 2030 | $2500 Million |
| Compound Annual Growth Rate | 18.1% |
| Regions Covered | Global |
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of COVID-19 Pandemic and Looming Global Recession
- With Viral Vector-based Vaccines Used for COVID-19 in Development, Viral Vector Manufacturing Market Poised to Benefit
- An Introduction to Viral Vector Manufacturing
- Applications of Viral Vectors
- Types of Viral Vectors
- Global Viral Vector Manufacturing Market: Prospects & Outlook
- Competition
- COVID-19 Pandemic Puts Pressure on Already Constrained Viral Vector Manufacturing Capacity
- A Glance at Select Investments in Expanding Viral Vector Manufacturing Capacity
- Recent Market Activity
- Viral Vector Manufacturing - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Increasing Prevalence of Infectious Diseases, Genetic Disorders & Cancers Drives Market
- Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
- Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
- Life Expectancy at Age 60 and 80 Years: (2010-2015), (2020-2025) & (2045-2050)
- Gene Therapy Emerges as a Major Therapeutic Approach for Inheritable and Acquired Diseases, Spurring Market Prospects
- Gene Therapy Set to Witness Rapid Growth Post COVID-19
- Viral Vectors Lead the Gene Therapy Market
- Adeno-Associated Virus Vectors: A Leading Platform for Gene Therapy
- Lentiviral Vectors Witness Increased Interest for Gene Therapy
- Funding Support for Gene Therapy Development Presents Market Opportunities
- Complexity in Viral Vector Production for Gene therapies
- Amidst Rising Cancer Incidence, Focus on Viral Vector-based Gene Therapies to Boost Market
- Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
- Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
- Number of New Cancer Cases and Deaths (in Million) by Region for 2018
- Engineered and Natural Oncolytic Viral Vectors: A Key Development in Viral Vector-based Cancer Therapy
- Growing Threat Posed by Infectious Diseases Drives Focus onto Vector Viral-based Therapies & Vaccines
- Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
- Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
- Rising Significance of Viral Vectors in New Vaccine Development
- Adenovirus-based Vaccines: Evolution Over the Years
- Viral Vector Emerges as a Next-Gen Platform for COVID-19 Vaccines Development
- Rush to Develop and Rollout COVID-19 Vaccines Boosts Prospects for Viral Vector Manufacturing
- COVID-19 Vaccines Under Development
- Vaccines in Pipeline by Technology
- Vaccine Technologies in Pre-Clinical Studies
- Replicating and Non-Replicating Viral Vector-Based Vaccines
- Non-Replicating Viral vector Vaccine in Clinical Development: As on December 2nd, 2020
- Replicating Viral vector Vaccine Candidate in Clinical Development: As on December 2nd, 2020
- Adenoviral Vectors: Frontrunners of New Vaccine for COVID-19
- Vaccines for COVID-19 Confronts Logistic Obstacles to Overcome
- Market to Benefit from the Emergence of New Technologies to Manufacture Viral Vectors
- New Trends for Optimizing Workflow Using Viral Vectors
- Production Workflow & Viral Vectors
- Closed-System-Adherent Culture of Cells: Recent Advances
- Limitations in Viral Vector Manufacturing Impact Market
- Innovations & Collaborations: Essential to Resolve Challenges Facing Large-Scale GMP Viral Vector Manufacturing
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/y4sxex
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
